Cargando…
Evaluating the Effect of Therapeutic Stem Cells on TRAIL Resistant and Sensitive Medulloblastomas
Mesenchymal stem cells (MSC) are emerging as novel cell-based delivery agents; however, a thorough investigation addressing their therapeutic potential in medulloblastomas (MB) has not been explored to date. In this study, we engineered human MSC to express a potent and secretable variant of a tumor...
Autores principales: | Nesterenko, Irina, Wanningen, Simone, Bagci-Onder, Tugba, Anderegg, Maarten, Shah, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492275/ https://www.ncbi.nlm.nih.gov/pubmed/23145127 http://dx.doi.org/10.1371/journal.pone.0049219 |
Ejemplares similares
-
Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015) -
Epigenetic Deregulation of Apoptosis in Cancers
por: Ozyerli-Goknar, Ezgi, et al.
Publicado: (2021) -
KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL
por: Kurt, Ibrahim Cagri, et al.
Publicado: (2017) -
IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
por: Kayabolen, Alisan, et al.
Publicado: (2021) -
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
por: Huang, Guo‐Hao, et al.
Publicado: (2016)